UAS
GILD icon

United Asset Strategies’s Gilead Sciences GILD Stock Holding History

United Asset Strategies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,347
Closed -$3.36M – 265
2025
Q4 		$3.36M Buy
27,347
+53
+0.2% +$6.44K 0.26% 71
2025
Q3 		$3.03M Sell
27,294
-523
-2% -$59.4K 0.24% 72
2025
Q2 		$3.08M Sell
27,817
-2,099
-7% -$223K 0.26% 72
2025
Q1 		$3.35M Sell
29,916
-874
-3% -$90.2K 0.31% 70
2024
Q4 		$2.84M Sell
30,790
-588
-2% -$52.9K 0.26% 75
2024
Q3 		$2.63M Sell
31,378
-261
-0.8% -$19.9K 0.25% 81
2024
Q2 		$2.17M Sell
31,639
-15,729
-33% -$1.05M 0.21% 87
2024
Q1 		$3.47M Buy
47,368
+845
+2% +$65K 0.35% 66
2023
Q4 		$3.77M Sell
46,523
-2,578
-5% -$201K 0.42% 62
2023
Q3 		$3.68M Buy
49,101
+20,520
+72% +$1.58M 0.48% 54
2023
Q2 		$2.2M Sell
28,581
-167
-0.6% -$13.3K 0.27% 80
2023
Q1 		$2.39M Buy
28,748
+44
+0.2% +$3.64K 0.31% 71
2022
Q4 		$2.46M Buy
28,704
+69
+0.2% +$5.46K 0.34% 72
2022
Q3 		$1.77M Buy
28,635
+112
+0.4% +$7.06K 0.27% 81
2022
Q2 		$1.76M Buy
28,523
+970
+4% +$60.1K 0.26% 79
2022
Q1 		$1.64M Buy
+27,553
New +$1.76M 0.21% 91
2020
Q2 		– Sell
-17,037
Closed -$1.27M – 195
2020
Q1 		$1.27M Buy
+17,037
New +$1.18M 0.32% 73
2019
Q3 		– Sell
-53,527
Closed -$3.62M – 188
2019
Q2 		$3.62M Sell
53,527
-1,430
-3% -$94.1K 0.83% 42
2019
Q1 		$3.57M Sell
54,957
-15,621
-22% -$1.04M 0.84% 41
2018
Q4 		$4.42M Sell
70,578
-4,532
-6% -$317K 1.21% 26
2018
Q3 		$5.8M Buy
75,110
+3,149
+4% +$238K 1.37% 22
2018
Q2 		$5.1M Buy
71,961
+7,015
+11% +$495K 1.35% 20
2018
Q1 		$4.9M Buy
64,946
+3,128
+5% +$249K 1.44% 19
2017
Q4 		$4.43M Sell
61,818
-9,008
-13% -$684K 1.19% 24
2017
Q3 		$5.74M Buy
70,826
+4,885
+7% +$374K 3.25% 4
2017
Q2 		$4.67M Sell
65,941
-19,403
-23% -$1.29M 1.38% 27
2017
Q1 		$5.8M Buy
85,344
+9,437
+12% +$664K 1.77% 16
2016
Q4 		$5.44M Buy
75,907
+6,123
+9% +$455K 1.77% 13
2016
Q3 		$5.52M Buy
69,784
+1,936
+3% +$157K 1.93% 13
2016
Q2 		$5.66M Buy
67,848
+6,483
+11% +$575K 2.12% 13
2016
Q1 		$5.64M Buy
61,365
+2,403
+4% +$217K 2.51% 10
2015
Q4 		$5.97M Buy
58,962
+2,030
+4% +$211K 2.59% 8
2015
Q3 		$5.59M Buy
56,932
+1,382
+2% +$153K 2.58% 7
2015
Q2 		$6.5M Buy
55,550
+2,883
+5% +$315K 2.91% 3
2015
Q1 		$5.29M Buy
52,667
+5,177
+11% +$526K 2.46% 9
2014
Q4 		$4.48M Buy
47,490
+24,900
+110% +$2.58M 1.91% 10
2014
Q3 		$2.4M Sell
22,590
-7,370
-25% -$722K 1.08% 39
2014
Q2 		$2.48M Buy
+29,960
New +$2.33M 1.2% 32

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

United Asset Strategies's GILD Position: Q1 2026 in Review

United Asset Strategies sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 27,347 shares — an estimated $3.36M sold.

United Asset Strategies first reported a position in GILD in Q2 2014 and held it in 38 quarters. The position peaked at $6.5M in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • United Asset Strategies reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • United Asset Strategies sold 27,347 Gilead Sciences shares in Q1 2026, an estimated $3.36M.
  • United Asset Strategies first reported a position in Gilead Sciences in Q2 2014 and held it in 38 quarters.
  • United Asset Strategies's Gilead Sciences position peaked at $6.5M in Q2 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on United Asset Strategies's 13F filing for Q1 2026, filed 29 Apr 2026.